FI112948B - Menetelmä lääkeaineena käyttökelpoisten 11beta-bentsaldoksiimi-17beta-metoksi-17alpha-metoksimetyyli-estra-4,9-dieeni-johdannaisten valmistamiseksi - Google Patents

Menetelmä lääkeaineena käyttökelpoisten 11beta-bentsaldoksiimi-17beta-metoksi-17alpha-metoksimetyyli-estra-4,9-dieeni-johdannaisten valmistamiseksi Download PDF

Info

Publication number
FI112948B
FI112948B FI943688A FI943688A FI112948B FI 112948 B FI112948 B FI 112948B FI 943688 A FI943688 A FI 943688A FI 943688 A FI943688 A FI 943688A FI 112948 B FI112948 B FI 112948B
Authority
FI
Finland
Prior art keywords
estra
methoxy
methoxymethyl
phenyl
progesterone
Prior art date
Application number
FI943688A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI943688A (fi
FI943688A0 (fi
Inventor
Walter Elger
Gerd Schubert
Guenther Kaufmann
Lothar Sobeck
Michael Oettel
Anatoli Kurischko
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of FI943688A0 publication Critical patent/FI943688A0/fi
Publication of FI943688A publication Critical patent/FI943688A/fi
Application granted granted Critical
Publication of FI112948B publication Critical patent/FI112948B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
FI943688A 1993-09-20 1994-08-09 Menetelmä lääkeaineena käyttökelpoisten 11beta-bentsaldoksiimi-17beta-metoksi-17alpha-metoksimetyyli-estra-4,9-dieeni-johdannaisten valmistamiseksi FI112948B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4332284A DE4332284C2 (de) 1993-09-20 1993-09-20 11-Benzaldoxim-17beta-methoxy-17alpha-methoxymethyl-estradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE4332284 1993-09-20

Publications (3)

Publication Number Publication Date
FI943688A0 FI943688A0 (fi) 1994-08-09
FI943688A FI943688A (fi) 1995-03-21
FI112948B true FI112948B (fi) 2004-02-13

Family

ID=6498354

Family Applications (1)

Application Number Title Priority Date Filing Date
FI943688A FI112948B (fi) 1993-09-20 1994-08-09 Menetelmä lääkeaineena käyttökelpoisten 11beta-bentsaldoksiimi-17beta-metoksi-17alpha-metoksimetyyli-estra-4,9-dieeni-johdannaisten valmistamiseksi

Country Status (19)

Country Link
EP (1) EP0648779B1 (pl)
JP (1) JP2696672B2 (pl)
KR (1) KR100190775B1 (pl)
AT (1) ATE149513T1 (pl)
AU (1) AU682373B2 (pl)
CA (1) CA2130515C (pl)
CZ (1) CZ289801B6 (pl)
DE (2) DE4332284C2 (pl)
DK (1) DK0648779T3 (pl)
ES (1) ES2102144T3 (pl)
FI (1) FI112948B (pl)
GR (1) GR3023644T3 (pl)
HU (1) HU219399B (pl)
NO (1) NO304988B1 (pl)
NZ (1) NZ264228A (pl)
PL (1) PL179460B1 (pl)
RU (1) RU2130944C1 (pl)
SK (1) SK280315B6 (pl)
UA (1) UA39101C2 (pl)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4332283A1 (de) * 1993-09-20 1995-04-13 Jenapharm Gmbh Neue 11-Benzaldoximestradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US5576310A (en) * 1994-09-20 1996-11-19 Jenapharm Gmbh 11-benzaldoxime-17β-methoxy-17α-methoxymethyl-estrasdiene derivatives, methods for their production and pharmaceuticals containing such compounds
DE19745085A1 (de) * 1997-10-11 1999-04-15 Jenapharm Gmbh 11ß-Benzaldoxim-9alpha,10alpha-epoxy-estr-4-en-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate
DE19809845A1 (de) 1998-03-03 1999-09-09 Jenapharm Gmbh S-substituierte 11beta-Benzaldoxim-estra-4,9-dien-kohlensäurethiolester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
DE19906152B4 (de) 1999-02-10 2005-02-10 Jenapharm Gmbh & Co. Kg Wirkstoffhaltige Laminate für Transdermalsysteme
US7629334B1 (en) * 1999-08-31 2009-12-08 Bayer Schering Pharma Aktiengesellschaft Mesoprogrestins (progesterone receptor modulations) as a component of compositions for hormone replacement therapy (HRT)
PL353994A1 (pl) * 1999-08-31 2003-12-15 Jenapharm Gmbh & Co.Kgjenapharm Gmbh & Co.Kg Mezoprogestyny (substancje modulujące receptory prMezoprogestyny (substancje modulujące receptory progesteronowe) jako składnik środków antykoncepcyjnogesteronowe) jako składnik środków antykoncepcyjnych dla kobietych dla kobiet
CZ301412B6 (cs) 1999-08-31 2010-02-24 Bayer Schering Pharma Aktiengesellschaft Použití specifických mesoprogestinu jako farmaceutické složky pro výrobu léciva pro hormonální substitucní lécbu
KR100864547B1 (ko) 1999-08-31 2008-10-20 바이엘 쉐링 파마 악티엔게젤샤프트 양성 호르몬 의존성 부인과 질병의 치료 및 예방을 위한메조프로게스틴 (프로게스테론 수용체 조절물질)
DE19961219A1 (de) * 1999-12-15 2001-07-19 Jenapharm Gmbh 11beta-Phenylestratrien-Derivate mit Fluoralkylgruppen in der aromatischen Seitenkette, deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
DE10056677A1 (de) * 2000-11-10 2002-05-16 Jenapharm Gmbh Verfahren zur Herstellung von 4-(17a-Alkoxymethyl-17ß-substituierten-3-oxoestra-4,9-dien-11ß-yl)benzaldehyd-(1E)-oxim-Derivaten
DE10056676A1 (de) * 2000-11-10 2002-05-16 Jenapharm Gmbh Verfahren zur Herstellung von 4-/17alpha-substituierten-3-oxoestra-4,9-dien-11beta-yl)benzaldehyd-(1E oder 1Z)-oximen
EP1285927A3 (de) * 2001-08-16 2005-06-29 Schering Aktiengesellschaft Verwendung von Glucocorticoid-Rezeptorantagonisten zur Vorbeugung und Behandlung von Erkrankungen des männlichen Reproduktionssystems
DE10221034A1 (de) 2002-05-03 2003-11-20 Schering Ag 17alpha-Fluoralkyl-11ß-benzaldoxim-Steroide, Verfahren zu deren Herstellung, diese Steroide enthaltende pharmazeutische Präparate sowie deren Verwendung zur Herstellung von Arzneimitteln
EP1525215B1 (de) * 2002-08-02 2006-09-06 Schering Aktiengesellschaft Progesteronrezeptormodulatoren mit erhöhter antigonadotroper aktivität für die weibliche fertilitätskontrolle und hormonersatztherapie
DE10236405A1 (de) 2002-08-02 2004-02-19 Schering Ag Progesteronrezeptormodulatoren mit erhöhter antigonadotroper Aktivität für die weibliche Fertilitätskontrolle und Hormonersatztherapie
DE102005059222B4 (de) * 2005-12-08 2007-10-11 Bayer Schering Pharma Ag 11ß-Benzaldoximderivate von D-Homoestra-4,9-dien-3-onen
SI3263112T1 (sl) 2006-10-24 2020-10-30 Allergan Pharmaceuticals International Limited Sestavki in metode za zaviranje endometrijskih proliferacij
TWI539953B (zh) 2008-04-28 2016-07-01 瑞波若斯治療學公司 用於治療乳癌之組成物和方法
KR102166867B1 (ko) 2010-03-22 2020-10-19 앨러간 파마슈티컬스 인터내셔널 리미티드 항프로게스틴의 비독성 전달을 위한 조성물들과 그 방법들

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU580843B2 (en) * 1985-02-07 1989-02-02 Schering Aktiengesellschaft 11``-phenyl-gonanes, their manufacture and pharmaceutical preparations containing them
DE3504421A1 (de) * 1985-02-07 1986-08-07 Schering AG, 1000 Berlin und 4709 Bergkamen Neue 11ss-phenyl-gonane, deren herstellung und diese enthaltende pharmazeutische praeparate
EP0411733B1 (de) * 1989-08-04 1998-10-21 Schering Aktiengesellschaft 11 Beta-Aryl-gona-4,9-dien-3-one
DE4332283A1 (de) * 1993-09-20 1995-04-13 Jenapharm Gmbh Neue 11-Benzaldoximestradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel

Also Published As

Publication number Publication date
HUT68315A (en) 1995-06-28
NO304988B1 (no) 1999-03-15
HU9402695D0 (en) 1994-11-28
CZ289801B6 (cs) 2002-04-17
NZ264228A (en) 1995-04-27
UA39101C2 (uk) 2001-06-15
CA2130515C (en) 2001-07-17
FI943688A (fi) 1995-03-21
FI943688A0 (fi) 1994-08-09
CZ196994A3 (en) 1995-04-12
JP2696672B2 (ja) 1998-01-14
CA2130515A1 (en) 1995-03-21
ES2102144T3 (es) 1997-07-16
EP0648779B1 (de) 1997-03-05
DE4332284A1 (de) 1995-03-23
EP0648779A3 (de) 1995-08-09
ATE149513T1 (de) 1997-03-15
PL179460B1 (pl) 2000-09-29
RU94029667A (ru) 1996-06-27
SK95894A3 (en) 1995-04-12
AU682373B2 (en) 1997-10-02
NO942952L (no) 1995-03-21
DE4332284C2 (de) 1997-05-28
KR950008531A (ko) 1995-04-19
JPH07149790A (ja) 1995-06-13
NO942952D0 (no) 1994-08-09
EP0648779A2 (de) 1995-04-19
SK280315B6 (sk) 1999-11-08
DE59401919D1 (de) 1997-04-10
HU219399B (hu) 2001-04-28
KR100190775B1 (ko) 1999-06-01
PL305091A1 (en) 1995-04-03
RU2130944C1 (ru) 1999-05-27
DK0648779T3 (da) 1997-09-15
GR3023644T3 (en) 1997-08-29
AU7035194A (en) 1995-03-30

Similar Documents

Publication Publication Date Title
FI113657B (fi) Menetelmä uusien 11beeta-bentsaldoksiimi-estra-4,9-dieeni-johdannaisten valmistamiseksi käytettäväksi farmaseuttisissa koostumuksissa
FI112948B (fi) Menetelmä lääkeaineena käyttökelpoisten 11beta-bentsaldoksiimi-17beta-metoksi-17alpha-metoksimetyyli-estra-4,9-dieeni-johdannaisten valmistamiseksi
US5576310A (en) 11-benzaldoxime-17β-methoxy-17α-methoxymethyl-estrasdiene derivatives, methods for their production and pharmaceuticals containing such compounds
KR20010041667A (ko) 호르몬 작용제 또는 길항제 성질을 갖는20-케토-11β-아릴스테로이드 및 그의 유도체
BG60768B2 (bg) Производни на заместени стероиди в 11 бета,метод за получаването им,приложението им като лекарствени средства и състави,които ги съдържат
US6365582B1 (en) S-substitute 11β-benzaldoxime-estra-4, 9-diene-carbonic acid thiolesters, method for the production thereof and pharmaceutical preparations containing these compounds
KR20010032127A (ko) 11β 위치에 치환된 신규한 19-노르스테로이드, 제조 방법및 중간체, 이들을 함유하는 의약품 및 제약 조성물로서의응용
KANEKO et al. Synthesis and Structure-Activity Relationships of 7α-Alkylthioandrostanes
RU2137777C1 (ru) ПРОИЗВОДНЫЕ 11β-БЕНЗАЛЬДОКСИМ-ЭСТРА-4,9-ДИЕНА, СПОСОБ ИХ ПОЛУЧЕНИЯ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ
DE19961219A1 (de) 11beta-Phenylestratrien-Derivate mit Fluoralkylgruppen in der aromatischen Seitenkette, deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
MXPA00007612A (en) S-SUBSTITUTED 11&bgr;-BENZALDOXIME-ESTRA-4,9-DIENE-CARBONIC ACID THIOLESTERS, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT

Free format text: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT